Drug intelligence / Profile preview

Ke Min Capsule

Development stage: Unknown
Lead developer: Jinan Kangzhong Pharmaceutical Technology Development
Administration: Oral

Overview

Ke Min Capsule (Ke Min Jiao Nang) is a Traditional Chinese Medicine (TCM) product developed by Jinan Kangzhong Pharmaceutical Technology Development for the treatment of post-infectious cough (PIC). It is specifically formulated to address the TCM pattern of "wind-cold lingering in the lung," a condition characterized by persistent coughing following a respiratory infection. The drug is currently being evaluated in Phase II clinical trials in China to determine the optimal dose and evaluate its efficacy and safety over a 14-day treatment period. As a botanical product, it likely utilizes a multi-component approach to dispel wind-cold and soothe the respiratory tract.

Brand names: Ke Min Capsule
Other names: Ke Min Jiao Nang咳敏胶囊

Beyond the preview

Go deeper on Ke Min Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ke Min Capsule.

Explore the full profile